We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance to Develop Pulmonary Therapy Device

By HospiMedica staff writers
Posted on 19 Dec 2001
An alliance to develop and manufacture a novel inhalation device for pulmonary therapy has been announced by Bespak (London, UK) and Battelle Pulmonary Therapeutics, Inc. More...
(BPT, Cary, NC, USA). BPT develops pulmonary delivery devices, drugs, formulations, and inhaled cancer therapies for the treatment of respiratory and systemic diseases. Bespak is a multinational company focused on the development and manufacture of drug delivery devices and technologies.

The electrohydrodynamic (EHD) aerosol delivery technology of BPT will be used to develop high-performance devices that can be used to deliver both topically and systemically active drug compounds to the lung with greater than 90% efficiency and without the need for liquid propellants or other pressurized systems. Under the terms of the agreement, Bespak will handle the development and industrialization of the program from its facilities in North Carolina (USA).

"Our combined expertise and resources will allow us to develop a device that may be the next standard for pulmonary therapies,” said William C. Zimlich, vice president of device product development for BPT.



Related Links:
Bespak
BPT

New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Glucose Meter
StatStrip®
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Allevion Medical receives FDA Clearance for Vantage, introducing a fully disposable approach to minimally invasive spinal decompression (photo courtesy of Allevion Medical)

Single-Use System Enables Minimally Invasive Decompression for Lumbar Spinal Stenosis

Lumbar spinal stenosis is frequently driven by hypertrophic bone that narrows the canal and produces pain. Conventional decompression often relies on larger incisions and bulky retractors, adding time,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.